Un programa de metadona pionero trata a las personas que usan drogas en Tanzania
En 2009, el gobierno de Tanzania declaró públicamente que las personas usuarias de drogas necesitan opciones de tratamiento basadas en pruebas empíricas. A raíz de ello, el Ministerio de Salud del país aprobó un plan integral para ayudar a prevenir y tratar la dependencia de la heroína. Más información, en inglés, está disponible abajo.
Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.
Every morning, hundreds of Tanzanians make their daily sojourn to a breezy open-air methadone clinic at Muhimbili National Hospital. The journey is not always smooth. Some travel on overcrowded local buses, and others walk for hours in Dar es Salaam’s sweltering heat.
One by one, the patients are called to a window, where a nurse behind a metal grate offers a plastic cup filled with liquid methadone. They drink the viscous concoction under her watchful eye, after which they can continue their day without craving heroin. “For a long time, I couldn’t live without heroin,” said Stamil Hamadi, a 34-year-old woman with a heart-shaped face and calming presence. “I decided to try methadone to become a new Stamil. My health began improving, and I started gaining weight.”
Muhimbili’s methadone clinic is the first of its kind in mainland sub-Saharan Africa. Few governments, donors or nonprofits in Africa work with heroin users. Médecins du Monde (MDM), an international nonprofit that serves heroin users in Tanzania, estimates that fewer than 1 percent of drug users on the continent have access to support services, let alone treatment plans like methadone.
Tanzania is a striking exception. In 2009 the national government publicly declared that its drug users needed evidence-based treatment options. With aid from the United States and Canada, Tanzania’s Ministry of Health approved a comprehensive plan to help prevent and treat heroin addiction.
Click here to read the full article.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.